Clinical Trial Update: A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression [Phase 4]

View source ↗

Summary

Clinical trial update for Esketamine Nasal Spray in Korean participants with treatment-resistant depression, in Phase 4 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Esketamine nasal spray (esketamine)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Depressive Disorder, Treatment-Resistant | Phase 4 | Status: RECRUITING